Today, Benzinga 's options scanner spotted 50 uncommon options trades for Palantir Technologies. This isn't normal. The ...
NeuroSense Therapeutics, Ltd. , a leading clinical-stage biotechnology company focused on developing treatments for severe neurodegenerative diseases, today announced that two members of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback